Hepatotoxicity Special Interest Group
Note: this meeting was held April 8-9, 2009
Recent Research Advances in Drug-Induced Liver Injury
A national/international discussion of recent new findings in the field of drug-induced liver injury (DILI), work in progress, and work that needs to be done.
The program was co-sponsored by the Food and Drug Administration/Center for Drug Evaluation and Research (FDA/CDER), the Pharmaceutical Research and Manufacturers of America (PhRMA), and AASLD.